These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6270295)

  • 1. Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.
    Hunt CA; Jones RT; Herning RI; Bachman J
    J Pharmacokinet Biopharm; 1981 Jun; 9(3):245-60. PubMed ID: 6270295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
    Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
    Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
    Alozie SO; Martin BR; Harris LS; Dewey WL
    Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
    Zuardi AW; Teixeira NA; Karniol IC
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated method for the simultaneous quantification of cannabidiol, Δ
    Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
    Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
    Brady KT; Balster RL
    Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
    Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ
    Palazzoli F; Citti C; Licata M; Vilella A; Manca L; Zoli M; Vandelli MA; Forni F; Cannazza G
    J Pharm Biomed Anal; 2018 Feb; 150():25-32. PubMed ID: 29202305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
    Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
    Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two cannabinoids on hepatic microsomal cytochrome P-450.
    Watanabe K; Hamajima K; Narimatsu S; Yamamoto I; Yoshimura H
    J Pharmacobiodyn; 1986 Jan; 9(1):39-45. PubMed ID: 3012058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
    Nagai K; Watanabe K; Narimatsu S; Gohda H; Matsunaga T; Yamamoto I; Yoshimura H
    Biol Pharm Bull; 1993 Oct; 16(10):1008-13. PubMed ID: 8287029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.